Sarcopenia is a progressive, generalized skeletal muscle disorder characterized by
reduction of muscle mass and strength. It is associated with increased adverse outcomes …

OBJECTIVE. The purpose of this article is to review the nomenclature, clinical impact, and
diagnostic techniques characterizing sarcopenia. CONCLUSION. Sarcopenia—defined as …

Sarcopenia is characterised by progressive and extensive skeletal muscle degeneration
and is associated with functional decline. Sarcopenia has primary and secondary aetiology …

To date, sarcopenia is considered a patient-specific imaging biomarker able to predict
clinical outcomes. Several imaging modalities, including dual-energy X-ray absorptiometry …

Sarcopenia indicates a loss of skeletal muscle mass, a condition that leads to a decline in
physical performance. In 2018, the European Working Group on Sarcopenia in Older People …

Recently, sarcopenia has garnered renewed interest. Sarcopenia is a disease characterized
by decreased skeletal muscle mass and strength/function, which can impair the quality of life …

By the sixth decade of life, nearly one quarter of the population has substantial muscle
atrophy, or sarcopenia. Despite the creation of a standardized definition of sarcopenia by the …

Background: Skeletal muscle depletion (sarcopenia) predicts morbidity and mortality in the
elderly and cancer patients. Methods: We tested whether sarcopenia predicts primary …

Sarcopenia refers to age‐associated decrease in muscle mass and function. The condition
was originally described in the elderly, but emerging evidence suggests that it is also a …

Background Sarcopenia is characterized by loss of skeletal muscle and strength, associated
with aging, poor nutrition, sedentary lifestyle, and long-term illness. We sought to evaluate …